Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 11, 2012, Pages 1756-1766

  Lois, Cristina ^a,b,c   Bezrukov, Ilja ^c,d   Schmidt, Holger ^c   Schwenzer, Nina ^c   Werner, Matthias K ^c   Kupferschläger, Jürgen ^c   Beyer, Thomas ^c,e  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Santiago University Clinical Hospital   (Spain)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d MAX PLANCK INSTITUTE FOR INTELLIGENT SYSTEMS   (Germany)

^e Max Plank Institute for Intelligent Systems ^*

Author keywords

Attenuation correction; Contrast agents; PET MR; Quantification

Indexed keywords

FERUMOXSIL; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GADOBUTROL; GALLIUM 68; IOMEPROL; IRON OXIDE;

ARTICLE; CONTROLLED STUDY; HUMAN; IMAGE QUALITY; LIMIT OF QUANTITATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATTERN RECOGNITION; PINEAPPLE JUICE; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE DIAGNOSIS; SIGNAL TRANSDUCTION; WHOLE BODY MRI; WHOLE BODY PET;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; CONTRAST MEDIA; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; SILOXANES; WHOLE BODY IMAGING;

EID: 84868191116     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2190-0     Document Type: Article

References (41)

1. Pichler BJ, Kolb A, Nägele T, Schlemmer HP. PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J Nucl Med. 2010;51:333-6.
2. Schulthess GK, Schlemmer H-PW. A look ahead: PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging. 2009;36 Suppl 1:S3-9.
3. Ratib O, Beyer T. Whole-body hybrid PET/MRI: ready for clinical use? Eur J Nucl Med Mol Imaging. 2011;38:992-5.
4. Budinger TF. Time-of-flight positron emission tomography: status relative to conventional PET. J Nucl Med. 1983;24:73-8.
5. Ratib O, BeckerM,Vallee JP, Loubeyre P,WissmeyerM,Willi J-P, et al. Whole body PET-MRI scanner: first experience in oncology [abstract]. J Nucl Med. 2010;51 Suppl 2:165.
6. Zaidi H, Ojha N, Morich M, Griesmer J, Hu Z, Maniawski P, et al. Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol. 2011;56:3091-106.
7. Delso G, Fürst S, Jakoby BJ, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52(12):1914-22.
8. von Schulthess GK, Burger C. Integrating imaging modalities: what makes sense from a workflow perspective? Eur J Nucl Med Mol Imaging. 2010;37:980-90.
9. Hofmann M, Pichler B, Schölkopf B, Beyer T. Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nucl Med Mol Imaging. 2009;36 Suppl 1:S93-104.
10. Martinez-Möller A, Souvatzoglou M, Delso G, Bundschuh RA, Chefd'hotel C, Ziegler SI, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med. 2009;50:520-26.
11. Schulz V, Torres-Espallardo I, Renisch S, Hu Z, Ojha N, Börnert P, et al. Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging. 2011;38(1):138-52.
12. Hofmann M, Bezrukov I, Mantlik F, Aschoff P, Steinke F, Beyer T, et al. MRI-based attenuation correction for whole-body PET/MRI: quantitative evaluation of segmentation-and atlas-based methods. J Nucl Med. 2011;52(9):1392-9.
13. Kinahan PE, Hasegawa BH, Beyer T. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. Semin Nucl Med. 2003;33:166-79.
14. Bellin MF. MR contrast agents, the old and the new. Eur J Radiol. 2006;60:314-23.
15. Cohade C, Osman M, Nakamoto Y, Marshall LT, Links JM, Fishman EK, et al. Initial experience with oral contrast in PET/ CT: phantom and clinical studies. J Nucl Med. 2003;44(3):412-6.
16. Antoch G, Freudenberg LS, Egelhof T, Stattaus J, Jentzen W, Debatin JF, et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med. 2002;43:1339-42.
17. Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF. To enhance or not to enhance? 18F-FDG and CTcontrast agents in dual modality 18F-FDG PET/CT. J Nucl Med. 2004;45 Suppl:56S-65S.
18. Wang YXJ, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol. 2001;11:2319-31.
19. Hahn PF, Stark DD, Lewis JM, Saini S, Elizondo G, Weissleder R, et al. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology. 1990;175(3):695-700.
20. Leung K. Ferumoxil. Molecular imaging and contrast agent database. Bethesda: National Center for Biotechnology Information; 2004-2010. http://www.ncbi.nlm.nih.gov/books/NBK22994/.
21. Tombach B, Heindel W. Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrol. Eur Radiol. 2002;12(6):1550-6.
22. Huppertz A, Rohrer M. Gadobutrol, a highly concentrated MRimaging contrast agent: its physicochemical characteristics and the basis for its use in contrast-enhanced MR angiography and perfusion imaging. Eur Radiol. 2004;14:M12-8.
23. Cheng KT. Gadobutrol. Molecular imaging and contrast agent database. Bethesda: National Center for Biotechnology Information; 2004-2010. http://www.ncbi.nlm.nih.gov/books/NBK23589/.
24. Dooley M, Jarvis B. Iomeprol. A review of its use as a contrast medium. Drugs. 2000;59(5):1169-86.
25. Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr. 1994;18(1):110-8.
26. Stark H, Woods J, Paul I, Hingorani R. Direct Fourier reconstruction in computer tomography. IEEE Trans Acoust Speech Signal Process. 1981;29:237-45.
27. Brambilla M, Secco C, Dominietto M, Matheoud R, Sacchetti G, Inglese E. Performance characteristics obtained for a new 3-dimensional lutetium oxyorthosilicate-based whole-body PET/CT scanner with the national electrical manufacturers association NU 2-2001 standard. J Nucl Med. 2005;46:2083-91.
28. National Electrical Manufacturers Association (NEMA). Standards publication NU 2-1994: performance measurements of positron emission tomographs. Washington, DC: NEMA; 1994.
29. National Electrical Manufacturers Association (NEMA). Standards publication NU 2-2007: performance measurements of positron emission tomographs. Rosslyn: NEMA; 2007.
30. Tropp J. Image brightening in samples of high dielectric constant. J Magn Reson. 2004;167:12-24.
31. Bai C, Shao L, Da Silva AJ, Zhao Z. A generalized model for the conversion from CT numbers to linear attenuation coefficients. IEEE Trans Nucl Sci. 2003;50(5):1510-5.
32. Riordan RD, Khonsari M, Jeffries J, Maskell GF, Cook PG. Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography: a preliminary evaluation. Br J Radiol. 2004;77:991-9.
33. Arrivé L, Coudray C, Azizi L, Lewin M, Hoeffel C, Monnier-Cholley L, et al. Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography. J Radiol. 2007;88:1689-94.
34. Mawlawi O, Erasmus JJ, Munden RF, Pan T, Knight AE, Macapinlac HA, et al. Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. AJR Am J Roentgenol. 2006;186:308-19.
35. Yau YY, Chan WS, Tam YM, Vernon P, Wong S, Coel M, et al. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? J Nucl Med. 2005;46:283-91.
36. Lee W, Park J, Kim KM, Ko I, Lim I, Kim JS, et al. Effects of MR contrast agents on PET quantitation in PET-MRI study [abstract]. J Nucl Med. 2011;52 Suppl 1:53.
37. Kramer H, Michaely HJ, Requardt M, Rohrer M, Reeder S, Reiser MF, et al. Effects of injection rate and dose on image quality in time-resolved magnetic resonance angiography (MRA) by using 1.0M contrast agents. Eur Radiol. 2007;17:1394-402.
38. Fritz-Hansen T, Rostrup E, Larsson HB, Søndergaard L, Ring P, Henriksen O. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med. 1996;36:225-31.
39. Robert P, Violas X, Santus R, Le Bihan D, Corot C. Optimization of a blood pool contrast agent injection protocol for MR angiography. J Magn Reson Imaging. 2005;21:611-9.
40. Samarin A, Burger C, Kuhn FP, Schmid DT, von Schulthess GK. The influence of bone attenuation on tracer uptake values of bone lesions of different composition in PET imaging. Eur J Nucl Med Mol Imaging. 2009;38 Suppl 2:S156.
41. Lim JS, Kim MJ, Myoung S, Park MS, Choi JY, Choi JS, et al. MR cholangiography for evaluation of hilar branching anatomy in transplantation of the right hepatic lobe from a living donor. AJR Am J Roentgenol. 2008;191(2):537-45.